Cat. No.: DIA-0230492
Product Information | |
---|---|
CAS No. | 915019-65-7 |
Synonyms | BEZ-235, BEZ235, Dactolisib |
Chemical Name | 2-Methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile |
Formula | C30H23N5O |
Molecular Weight | 469.54 |
PubChem CID | 11977753 |
SMILES | CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5 |
Target | PI3K and mTOR |
Product Description | Potent PI3K and mTOR inhibitor |
Format & Storage | |
---|---|
Format | Solid |
Purity | > 98% |
Source | Synthetic |
Shipping | Shipped at room temperature. |
Storage | Store at -20 °C. Store under desiccating conditions. |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.